Logo for Salarius Pharmaceuticals Inc

Salarius Pharmaceuticals Investor Relations Material

Latest events

Logo for Salarius Pharmaceuticals Inc

Q2 2022

Salarius Pharmaceuticals
Logo for Salarius Pharmaceuticals

Q4 2023

22 Mar, 2024
Logo for Salarius Pharmaceuticals

Q3 2023

9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Salarius Pharmaceuticals Inc

Access all reports
Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focuses on developing epigenetic-based cancer treatments. Salarius Pharmaceuticals, Inc. is developing a new class of DNA-targeted anticancer agents that enable the suppression of tumor growth by reversing the aberrant epigenetic changes found in cancer cells. These DNA targeted agents are produced in a fully scalable process that allows rapid scale up to meet commercial demands and enable quick entry into clinical trials.